Eighty-five patients [21.0%, 14 missing] had clinical IBD activity, 93 patients [23.0%, 57 missing] had biochemical disease activity [elevated CRP or FCP], and 68 patients [16.8%, 176 missing] had an elevated FCP. This evidence concerns the gene CRP and inflammatory bowel disease.